Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-14 Purchase |
2025-04-15 07:59 am |
TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director |
325 | $1.0018 | $326 | 29,112 (Indirect Direct) |
View |
| 2025-04-14 Purchase |
2025-04-15 07:59 am |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
490 | $0.9985 | $489 | 73,639 (Direct) |
View |
| 2025-04-09 Purchase |
2025-04-10 4:29 pm |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
2,303 | $0.86583 | $1,994 | 73,149 (Direct) |
View |
| 2024-08-22 Purchase |
2024-08-26 5:40 pm |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
4,094 | $1.734 | $7,099 | 52,016 (Direct) |
View |
| 2024-08-21 Purchase |
2024-08-23 6:18 pm |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
1,200 | $1.6988 | $2,039 | 47,922 (Direct) |
View |
| 2023-12-06 Sale |
2023-12-07 4:51 pm |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
19,050 | $2.2931 | $43,684 | 62,565 (Direct) |
View |
| 2023-04-26 Sale(A) |
2023-05-04 4:38 pm |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
692 | $3.6381 | $2,518 | 15,081 (Direct) |
View |
| 2023-04-12 Sale |
2023-04-14 7:20 pm |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
1,170 | $3.6543 | $4,276 | 19,239 (Direct) |
View |
| 2023-01-26 Sale |
2023-01-30 6:40 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
1,697 | $5.0799 | $8,621 | 11,853 (Direct) |
View |
| 2023-01-23 Sale |
2023-01-25 5:50 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
1,309 | $5.3381 | $6,988 | 7,610 (Direct) |
View |
| 2022-12-09 Purchase |
2022-12-12 11:14 am |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner |
14,825 | $6.09 | $90,284 | 1,757,191 (Indirect) |
View |
| 2022-12-06 Sale |
2022-12-09 7:41 pm |
TherapeuticsMD Inc. | TXMD | Bernick Brian Co-Chief Executive Officer |
1,255 | $5.2761 | $6,621 | 49,596 (Indirect Direct) |
View |
| 2022-12-06 Sale |
2022-12-09 7:38 pm |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
1,048 | $4.9475 | $5,185 | 10,776 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-09 7:38 pm |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Co-Chief Executive Officer |
440 | $4.9215 | $2,165 | 4,760 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-09 7:37 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance |
910 | $4.775 | $4,345 | 6,519 (Direct) |
View |
| 2022-12-07 Purchase |
2022-12-09 10:58 am |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner |
20,413 | $5.665 | $115,639 | 1,742,366 (Indirect) |
View |
| 2022-12-07 Sale |
2022-12-08 8:10 pm |
TherapeuticsMD Inc. | TXMD | Naughton Gail K Director |
3,922 | $5.2614 | $20,635 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Exercise |
2025-02-20 9:08 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
8,500 | $0 | 60,516 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-20 9:07 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Naughton Gail K Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-20 9:07 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director |
8,500 | $0 | 28,787 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-20 9:07 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
8,281 | $0 | 72,579 (Direct) |
View |
| 2023-12-05 Exercise |
2023-12-07 4:51 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
70,000 | $0 | 62,565 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-17 09:27 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim See Remarks. 10% Owner |
877,192 | $2.28 | 2,946,908 (Indirect) |
View |
| 2023-08-17 Option Award |
2023-08-21 4:22 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | ZIEGLER JOSEPH Principal Financial Officer |
7,500 | $0 | 7,500 (Direct) |
View |
| 2023-07-17 Option Award |
2023-07-19 5:29 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2023-07-17 Option Award |
2023-07-19 5:28 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Naughton Gail K Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2023-07-17 Option Award |
2023-07-19 5:27 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 5:21 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim See Remarks 10% Owner |
312,525 | $3.6797 | 2,069,716 (Indirect) |
View |
| 2023-04-26 Exercise(A) |
2023-05-04 4:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
2,744 | $0 | 15,081 (Direct) |
View |
| 2023-04-12 Exercise |
2023-04-14 7:20 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
7,508 | $0 | 19,239 (Direct) |
View |
| 2023-04-12 Exercise |
2023-04-14 7:17 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
50,000 | $0 | 61,853 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 5:16 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 5:11 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-12-08 Ownership |
2023-02-13 5:23 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer |
716 | $0 | 5,969 (Direct) |
View |
| 2023-01-26 Exercise |
2023-01-30 6:40 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
5,940 | $0 | 11,853 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 5:50 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
4,365 | $0 | 7,610 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-09 7:41 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Bernick Brian Co-Chief Executive Officer |
3,167 | $0 | 49,596 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-09 7:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel |
2,554 | $0 | 10,776 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-09 7:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Glickman Mark A Co-Chief Executive Officer |
1,734 | $0 | 4,760 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-09 7:37 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance |
3,476 | $0 | 6,519 (Direct) |
View |
| 2022-09-29 Option Award |
2022-10-03 6:43 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Russell Angus C. Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-09-29 Option Award |
2022-10-03 6:40 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | BISARO PAUL Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-09-29 Option Award |
2022-10-03 6:39 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director |
34,175 | $0 | 34,175 (Direct) |
View |
| 2022-09-29 Option Award |
2022-10-03 6:39 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-09-29 Option Award |
2022-10-03 6:38 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Naughton Gail K Director |
5,000 | $0 | 5,000 (Direct) |
View |